The correct interpretation of any result depends on the biological model, assay sensitivity, positive and negative controls, exposure period, analytical method, and the reproducibility of the dataset
According to results published in NEJM, Mounjaro achieved A1C reductions of 2.01% (5mg), 2.24% (10mg), and 2.30% (15mg) versus 1.86% with semaglutide 1mg
Additional information We neither offer nor purport to offer any medical advice on this website, our official social media channels, via our customer service personnel nor via any approved affiliates
Patients considering low-dose GLP-1 therapy should undergo thorough evaluation, including assessment of contraindications, baseline inflammatory markers if appropriate, and regular monitoring for adverse effects